Lotronex Articles
Solvay updates on R&D progress
24 February 2003
Hopes recede on future of GSK's Lotronex?
4 February 2002
GSK drops late-stage diabetes drug
23 October 2001
GSK drops restenosis drug tranilast
25 July 2001
GSK pleased with start to 2001
23 May 2001
Belgium's Solvay looks for IBS partner
13 March 2001
GSK fills product gap by licensing Merck KGaA antidepressant
15 February 2001
Glaxo Wellcome/SmithKline Beecham merger completed at last
3 January 2001
Healthy harvest of New Chemical Entities in 2000
2 January 2001
Novartis R&D day updates prospects for key pipeline drugs
7 December 2000
Stock Commentary - Europe
7 December 2000
Stock Commentary - Europe
30 November 2000
Stock Commentary - Europe
16 November 2000
New US side-effect warning for Glaxo Wellcome's Lotronex?
16 November 2000
Public group demands Lotronex removal
1 November 2000
Strong earnings growth for Glaxo Wellcome and SmithKline Beecham
1 November 2000
Consumer group demands Lotronex ban
1 September 2000
Stock Commentary Europe
6 July 2000
Glaxo Wellcome delays start of Lotronex ad campaign
14 June 2000
Glaxo SmithKline merger "makes cents"
5 June 2000
Novartis says 25% chance Zelmac NDA will not be accepted
22 February 2000
Novartis files for approval of IBS therapy
17 February 2000
GW gets US approval for Lotronex, first treatment for IBS
10 February 2000
Glaxo SmithKline, an R&D powerhouse and global number one
17 January 2000
Stock Commentary Europe
6 January 2000
GW seeks backing for Trizivir, new HIV combo
20 December 1999
Stock Commentary Europe
2 December 1999
Stock Commentary Europe
25 November 1999
Stock Commentary Europe
18 November 1999
Glaxo Wellcome Jan-Oct trading results see sales up 6%
17 November 1999
Lotronex comparative study in IBS published
4 November 1999
Stock Commentary Europe
2 September 1999
Fast-track approval for GW's Lotronex (update)
31 August 1999
Fast-track approval for GW's Lotronex?
24 August 1999
GW struggles to post FY double-digit growth
27 July 1999
Stock Commentary Europe
8 July 1999
GW's IBS drug will be filed next month
20 May 1999
Showing 1-64 of 64 articles
- 1
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Negative US patent ruling for Novo Nordisk on Prandin
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Daiichi Sankyo files for Japanese approval of Prasugrel
